Unterrainer C - Search Results

1

Rare Malignant Indications for Liver Transplantation: A Collaborative Transplant Study Report.

Houben P, Schimmack S, Unterrainer C, Döhler B, Mehrabi A, Süsal C. Houben P, et al. Among authors: unterrainer c. Front Surg. 2021 Dec 3;8:678392. doi: 10.3389/fsurg.2021.678392. eCollection 2021. Front Surg. 2021. PMID: 34926560 Free PMC article.

2

Pitfalls in graft survival analysis.

Unterrainer C, Döhler B, Süsal C. Unterrainer C, et al. HLA. 2018 Feb;91(2):80-87. doi: 10.1111/tan.13191. HLA. 2018. PMID: 29220104 Review.

3

Relevance of donor-specific antibody monitoring after kidney transplantation: Findings from the Collaborative Transplant Study and the Heidelberg Transplant Center.

Süsal C, Aykut G, Morath C, Fichtner A, Unterrainer C, Scherer S, Tran TH, Mehrabi A, Zeier M, Tönshoff B. Süsal C, et al. Among authors: unterrainer c. HLA. 2019 Dec;94 Suppl 2:11-15. doi: 10.1111/tan.13665. HLA. 2019. PMID: 31403240

4

The collaborative transplant study registry.

Opelz G, Döhler B, Ruhenstroth A, Cinca S, Unterrainer C, Stricker L, Scherer S, Gombos P, Süsal C, Daniel V, Tran H. Opelz G, et al. Among authors: unterrainer c. Transplant Rev (Orlando). 2013 Apr;27(2):43-5. doi: 10.1016/j.trre.2013.01.004. Epub 2013 Mar 5. Transplant Rev (Orlando). 2013. PMID: 23465693 Review.

5

Immunosuppression with mammalian target of rapamycin inhibitor and incidence of post-transplant cancer in kidney transplant recipients.

Opelz G, Unterrainer C, Süsal C, Döhler B. Opelz G, et al. Among authors: unterrainer c. Nephrol Dial Transplant. 2016 Aug;31(8):1360-7. doi: 10.1093/ndt/gfw088. Epub 2016 May 4. Nephrol Dial Transplant. 2016. PMID: 27190384

6

Efficacy and safety of antibody induction therapy in the current era of kidney transplantation.

Opelz G, Unterrainer C, Süsal C, Döhler B. Opelz G, et al. Among authors: unterrainer c. Nephrol Dial Transplant. 2016 Oct;31(10):1730-8. doi: 10.1093/ndt/gfw086. Epub 2016 May 4. Nephrol Dial Transplant. 2016. PMID: 27190386

7

Pretransplant Cancer in Kidney Recipients in Relation to Recurrent and De Novo Cancer Incidence Posttransplantation and Implications for Graft and Patient Survival.

Unterrainer C, Opelz G, Döhler B, Süsal C; Collaborative Transplant Study. Unterrainer C, et al. Transplantation. 2019 Mar;103(3):581-587. doi: 10.1097/TP.0000000000002459. Transplantation. 2019. PMID: 30418430

8

Can PIRCHE-II Matching Outmatch Traditional HLA Matching?

Unterrainer C, Döhler B, Niemann M, Lachmann N, Süsal C. Unterrainer C, et al. Front Immunol. 2021 Feb 26;12:631246. doi: 10.3389/fimmu.2021.631246. eCollection 2021. Front Immunol. 2021. PMID: 33717167 Free PMC article.

9

Outcome of Extended Right Lobe Liver Transplantations.

Lozanovski VJ, Unterrainer C, Döhler B, Süsal C, Mehrabi A. Lozanovski VJ, et al. Among authors: unterrainer c. Liver Transpl. 2022 May;28(5):807-818. doi: 10.1002/lt.26374. Epub 2021 Dec 13. Liver Transpl. 2022. PMID: 34806843

10

Analysis of de novo donor-specific HLA-DPB1 antibodies in kidney transplantation.

Tang C, Unterrainer C, Fink A, Cinca S, Ruhenstroth A, Scherer S, Morath C, Zeier M, Mehrabi A, Süsal C, Tran TH. Tang C, et al. Among authors: unterrainer c. HLA. 2021 Nov;98(5):423-430. doi: 10.1111/tan.14422. Epub 2021 Sep 14. HLA. 2021. PMID: 34480415

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

27 results

Search Page